acquired
Stage
1
Investors
About
Optonol Ltd. developed the Ex-Press™ microscopic glaucoma shunt, a medical device implant designed to reduce intraocular pressure in glaucoma patients to help manage the disease surgically.
Explore Optonol Ltd.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.